VolitionRX Limited Common Stock (VNRX)
Stock · AMEX · Health Care
$0.18as of 10/16/2026
Price chart
Active signals
VNRX Signal Track Record
How signals performed across all stocks →What VNRX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 29 | -1.7% | 45% | July 15, 2026 |
| Bollinger Band Breakout | 19 | -15.5% | 26% | May 22, 2026 |
| Volume Spike | 18 | -6.4% | 44% | October 1, 2026 |
| 200-Day Moving Average TouchActive now | 10 | -6.3% | 30% | September 23, 2025 |
| Any 20-session window (baseline) | -8.0% | 31% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About VNRX
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provide…
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Employees
- 57
- Website
- volition.com/
Fundamentals
- 1-day range
- $0.1757$0.1829
- Market cap
- $9.23M
- P/E (trailing)
- —
- P/E (forward)
- -0.21
- EPS (trailing)
- $-3.80
- Dividend yield
- —
- Beta
- 1.15
- Avg. volume
- 8.52M
How VolitionRX Limited Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
5 analyst ratings
VolitionRX Limited Common Stock Competitors
Chosen by industry and closest market cap.
- VNRXVolitionRX Limited Common Stock$0.18▼ 5.26%Market cap $9.23MP/E —$0.18$10.31
- TRIBTrinity Biotech plc American Depositary Shares$8.03▲ 1.26%Market cap $7.86MP/E —$5.01$52.5
- BMRABiomerica Inc. Common Stock$1.85▼ 1.60%Market cap $4.94MP/E —$1.45$3.21
- CDIOCardio Diagnostics Holdings Inc. Common stock$1.69▼ 3.98%Market cap $4.91MP/E —$0.97$7.91
- VRAXVirax Biolabs Group Limited Ordinary Shares$1.45▼ 10.49%Market cap $2.21MP/E —$1.55$21.75
- CDIOWCardio Diagnostics Holdings Inc. Warrant$0.0064▼ 28.09%Market cap $50.3KP/E —$0.0052$0.0721
- QCLSQ/C Technologies Inc. Common Stock$0.538▼ 3.58%Market cap $21.99MP/E —$0.4201$8.17
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| VNRX VolitionRX Limited Common Stock | $9.23M | — | $0.18 | ▼ 5.26% | $0.18$10.31 |
| TRIB Trinity Biotech plc American Depositary Shares | $7.86M | — | $8.03 | ▲ 1.26% | $5.01$52.5 |
| BMRA Biomerica Inc. Common Stock | $4.94M | — | $1.85 | ▼ 1.60% | $1.45$3.21 |
| CDIO Cardio Diagnostics Holdings Inc. Common stock | $4.91M | — | $1.69 | ▼ 3.98% | $0.97$7.91 |
| VRAX Virax Biolabs Group Limited Ordinary Shares | $2.21M | — | $1.45 | ▼ 10.49% | $1.55$21.75 |
| CDIOW Cardio Diagnostics Holdings Inc. Warrant | $50.3K | — | $0.0064 | ▼ 28.09% | $0.0052$0.0721 |
| QCLS Q/C Technologies Inc. Common Stock | $21.99M | — | $0.538 | ▼ 3.58% | $0.4201$8.17 |
P/E shows — for peers not currently carrying a live signal of their own.
See the full, filterable feed with live charts on the MarketWall dashboard.